Pathophysiological concepts, prevalence, therapeutical options, and course of TE-CSA - 2025 Sleep and Breathing conference

Treatment emerging central sleep apnoea

Chair(s): Anita Simonds

Session type: Meet the Experts

Pathophysiological concepts, prevalence, therapeutical options, and course of TE-CSA

Dries Testelmans

EVENTS HOME

Replay
Slides

Previous presentation

Next presentation

Session content

The different faces of TE-CSA: treatment-emergent treatment-persistent treatment-resistant central sleep apnoea

Sébastien Baillieul

Replay

Slides

Introduction

Replay

Pathophysiological concepts, prevalence, therapeutical options, and course of TE-CSA

Dries Testelmans

Replay

Slides

Discussion and Q&A

Replay

Session aims

Differentiate between treatment-emergent, persistent, and resistant CSA through clinical case analysis. Understand the pathophysiology, prevalence, and progression of TE-CSA. Evaluate therapeutic options for managing TE-CSA effectively.

Sleep and Breathing Conference

10-12 April 2025 | Antwerp, Belgium

The eighth conference organised by the ERS and the ESRS

#{title}